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Staphylococcus aureus infection is a common cause of mastitis, reducing milk yield,
affecting animal welfare and causing huge economic losses within the dairy industry. In
addition to the problem of acquired drug resistance, bacterial invasion into udder cells
and the formation of surface biofilms are believed to reduce antibiotic efficacy, leading
to treatment failure. Here, we investigated the antimicrobial activities of enrofloxacin, an
antibiotic that is commonly used in mastitis therapy and polyhexamethylene biguanide
(PHMB), an antimicrobial polymer. The antimicrobial activities were tested against
intracellular S. aureus in infected Mac-T cells (host cells). Also, fluorescein-tagged
PHMB was used to study PHMB uptake and localization with S. aureus within the
infected Mac-T cells. Anti-biofilm activities were tested by treating S. aureus biofilms
and measuring effects on biofilm mass in vitro. Enrofloxacin and PHMB at 15 mg/L killed
between 42 to 92 and 99.9% of intracellular S. aureus, respectively. PHMB-FITC entered
and colocalized with the intracellular S. aureus, suggesting direct interaction of the drug
with the bacteria inside the host cells. Enrofloxacin and PHMB at 15 mg/L reduced
between 10 to 27% and 28 to 37% of biofilms’ mass, respectively. The half-maximal
inhibitory concentrations (IC50) obtained from a cytotoxicity assay were 345 ± 91 and
21 ± 2 mg/L for enrofloxacin and PHMB, respectively; therefore, both compounds
were tolerated by the host cells at high concentrations. These findings suggest that
both antimicrobials are effective against intracellular S. aureus and can disrupt biofilm
structures, with PHMB being more potent against intracellular S. aureus, highlighting the
potential application of PHMB in mastitis therapy.
Keywords: mastitis, S. aureus, intracellular bacteria, antimicrobial polymer, enrofloxacin, polyhexamethylene
biguanide
INTRODUCTION
Bovine mastitis causes huge economic losses in the dairy industry (Huijps et al., 2008). The disease
has been identified as the most common cause of morbidity in adult dairy cows in the United States
(USDA, 2007). Mastitis is manifested by inflammation of the mammary gland, triggered by bacteria
invasion through the teat canal (Gruet et al., 2001). A range of Gram-negative and -positive
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bacteria, mycoplasmas and algae are associated with mastitis. The
majority of cases appear to be caused by Eschericia coli (E. coli),
Streptococcus uberis (S. uberis), and S. aureus (Cheng et al., 2010;
Zadoks et al., 2011). S. aureus is associated with up to 30% of
bovine mastitis cases, causing sub-clinical and chronic infections
in the mammary gland (Weber et al., 2006; Halasa et al., 2007).
S. aureus produces toxins that can induce necrosis (cell death) of
milk secretory tissues, reducing milk production and food safety
(Zhao and Lacasse, 2008).
The recommended treatment for mastitis is administration
of antibiotics, with beta lactams (e.g., penicillin), tetracyclines
and enrofloxacin among the most widely used drugs. However,
cure rates for mastitis caused by S. aureus range from 4 to
92% (Barkema et al., 2006). Acquired resistance toward these
antibiotics has reduced therapy success rates (Pyörälä and
Pyörälä, 1998). Also, S. aureus is known to invade and localize
inside host alveolar cells and macrophages (Hébert et al., 2000;
Brouillette et al., 2003). Poor accumulation of beta lactams inside
the host cells leads to in-complete clearance of the bacteria
(Tulkens, 1991). Moreover, recent evidence by Silva et al. (2014)
demonstrated that enrofloxacin induces E. coli internalization by
bovine mammary alveolar cells.
The treatment for S. aureus mastitis is further complicated
by the formation of bacterial biofilms on the mammary gland.
Biofilms are structured communities of bacterial cells enclosed
in a self-produced polymeric matrix and adherent to an inert
or living surface (Melchior et al., 2006). The extracellular
polymeric substances (EPS) are built of polysaccharide, protein,
extracellular DNA, and lipids (Arciola et al., 2015; Roy
et al., 2017). Bacteria in biofilms are up to 1000-fold less
susceptible to antimicrobials (Ceri et al., 1999). Reduced
susceptibility is believed to be due to restricted diffusion of
drugs across the biofilm structure (Melchior et al., 2006) and
physiological changes in the bacteria resident within biofilms
(e.g., slower growth) may further reduce susceptibility (Costerton
et al., 1999). Furthermore, a recent study demonstrated
that enrofloxacin at sub-minimum inhibitory concentrations
induces biofilm formation by E. coli and S. aureus (Costa
et al., 2012; Seixas et al., 2015). Together; antimicrobial
resistance, host cellular invasion and formation of biofilms,
can lead to therapeutic failures, subsequently, causing persistent
mastitis in the animal. Therefore, there is an urgent need
to find alternative therapies to reduce the burden of the
disease.
No new antimicrobials effective against mastitis have been
developed during recent decades, and there is increasing concern
about antimicrobial resistance in food systems. Given that
mastitis therapy is typically administered locally, there may be
scope for using antimicrobial polymers in therapy. Antimicrobial
polymers appear much less susceptible to acquired resistance, and
they can be surprisingly effective against intracellular pathogens.
For example, we recently reported that a cationic polymer,
polyhexamethylene biguanide (PHMB) (Figure 1), effectively
killed intracellular S. aureus inside keratinocytes and the parasite
Leishmania in macrophages, through a dynamin dependent
uptake mechanism (Firdessa et al., 2015; Kamaruzzaman et al.,
2016). Therefore, we considered that PHMB might also be
effective against intracellular S. aureus within bovine mammary
epithelial cells. Similarly, we considered that the cell penetration
and DNA binding properties of PHMB (Chindera et al.,
2016) may enable this polymer to enter or destabilize biofilm
structures.
Here we tested the potential for PHMB to enter bovine
mammary epithelial cells and kill S. aureus that are sequestered
within the host cells. Three recent clinical isolates of S. aureus
from clinical cases of bovine mastitis were included. Also, we
tested anti-biofilm effects against the clinical isolates. We use
the term anti-biofilm to refer to “a natural or induced processes,
leading to reduction of bacterial biomass through the alteration
of biofilm formation, integrity and in quality” as suggested by
Miquel et al. (2016). For a comparison, we included enrofloxacin
(Figure 1), a fluoroquinolone that can enter mammalian cells and
has anti-biofilm activity (Van Bambeke et al., 2005; Benoit et al.,
2010).
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Staphylococcus aureus strain 15 AL was obtained from Dr.
Shan Goh, Royal Veterinary College, London strain 59 and
204 was obtained from Dr. Marjorie Bardiau, University
of Brighton. The three strains were selected because they
produce biofilms and are recent field isolates (Bardiau et al.,
2013; Prenafeta et al., 2014). Bacteria were grown in Mueller
Hinton Broth (MHB, Sigma–Aldrich, United Kingdom) followed
by incubation at 250 rpm (for liquid cultures), at 37◦C
for 18 h.
Eukaryotic Cell Lines and Growth
Conditions
Mac-T cells used as the host for intracellular infection
were obtained from Dr. Amanda Gibson (Royal Veterinary
College). The cells were maintained in DMEM with 10%
FBS (Sigma–Aldrich, United Kingdom), supplemented with 5%
penicillin-streptomycin (Sigma–Aldrich, United Kingdom) and
1% insulin. Cells were maintained at 37◦C in 5% carbon dioxide.
Determination of Minimum Inhibitory
Concentrations (MIC)
Enrofloxacin were purchased from Sigma–Aldrich,
United Kingdom. PHMB and fluorescein-tagged PHMB
(PHMB-FITC) were from Tecrea Ltd, United Kingdom. All
antimicrobials were prepared in stock solution at 10, 000 mg/L.
Enrofloxacin was dissolved in 0.02 M sodium hydroxide and
PHMB were dissolved in sterile distilled water.
minimum inhibitory concentrations (MICs) were determined
using the broth microdilution method (CLSI, 2007). Briefly, a
range of concentrations of antimicrobials were prepared in a
96-well microplate, followed by inoculation of bacteria to yield
∼5 × 105 cfu/mL in a 250 µl final volume. The plate was
then incubated at 37◦C for 18 h. The lowest concentration of
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FIGURE 1 | Structure of (A) enrofloxacin and (B) polyhexamethylene biguanide (PHMB). Enrofloxacin is a fluoroquinolone with mw of 359.4 g/mol. PHMB is a
cationic polymer of repeating hexamethylene biguanide groups, with n average = 10–12 (n is the number of structural unit repeats) and molecular weight (mw)
3025 g/mol.
antimicrobial that inhibited growth of bacteria was scored as
the MIC.
Intracellular Infections of Mac-T by
S. aureus
Intracellular infections of Mac-T cells by S. aureus were
established using a gentamicin protection procedure as described
in our previous work (Kamaruzzaman et al., 2016). Briefly, Mac-T
cells were co-incubated with S. aureus for 3 h for cellular invasion,
followed by gentamicin exposure at 200 mg/L for another 3 h to
kill extracellular bacteria. Finally, cells were lysed with one ml of
0.5% Triton X-100, prepared in PBS to release the intracellular
bacteria.
Visualization of Intracellular S. aureus
Within Bovine Mammary Epithelial Cells
Cells were grown on glass cover slips in a 12 wells plate
followed by S. aureus infections as described above. Following
gentamicin exposure to kill extracellular bacteria, cells were
rinsed with PBS and fixed with 4% paraformaldehyde (Santa
Cruz Biotechnology, United Kingdom). Cells were stained
with 5 mg/L DAPI (Life technologies, United Kingdom) for
nuclei staining and 5 mg/L Wheat Germ Agglutinin-conjugated
Alexa Fluor 555 (WGA, Life technologies, United Kingdom)
for membrane staining. Cover slips were mounted onto glass
slides with FluorSaveTM (Calbiochem, United Kingdom). Images
were visualized using a Leica SP5 confocal microscope using
Advanced Fluorescence Software (Leica Microsystems, Milton
Keynes, United Kingdom).
Intracellular Killing Activities of S. aureus
by Enrofloxacin and PHMB
Host cells were infected with S. aureus followed by incubation
with gentamicin to kill extracellular bacteria. Following
gentamicin exposure, cells were rinsed with PBS, and
antimicrobials (enrofloxacin or PHMB in medium) were
added to the wells containing the infected cells, and the plates
were incubated for another 3 h. Following this procedure,
the antimicrobials solutions were removed. Cells were then
rinsed and lysed. Lysed cells were serially diluted and plated
on nutrient agar. For each experiment, gentamicin treated
cells (without enrofloxacin or PHMB treatments) were used as
controls.
Visualization and Quantification of PHMB
Uptake into Mac-T Cells
Mac-T cells were grown on glass cover slips in a 12 wells
plate followed by S. aureus infections as described above.
Following gentamicin exposure to kill extracellular bacteria, cells
were rinsed with PBS and fixed with 4% paraformaldehyde
(Santa Cruz Biotechnology, United Kingdom). Cells were stained
with 5 mg/L DAPI (Life technologies, United Kingdom) for
nuclei staining and 5 mg/L Wheat Germ Agglutinin-conjugated
Alexa Fluor 555 (WGA, Life technologies, United Kingdom)
for membrane staining. Cover slips were mounted onto glass
slides with FluorSaveTM (Calbiochem, United Kingdom). Images
were visualized using a Leica SP5 confocal microscope using
Advanced Fluorescence Software (Leica Microsystems, Milton
Keynes, United Kingdom). Sequential scan Z-stacks (130 slices
1024 × 1024) were compiled at a line average of 96, using
Volocity R© software. Three-dimensional (3D) Image Analysis
Software was used for analysis and to produce 3D images.
To quantify PHMB uptake into Mac-T cells, PHMB-FITC
treated cells were incubated with 0.04% Trypan blue (Invitrogen,
United Kingdom) in PBS for 15 minutes to quench membrane
bounded PHMB-FITC, followed by flow cytometry (FACSBD
machine and BDFACSDivaTM software, BD Bioscience) using
the FITC filter. For each sample, 10,000 gated cells were
analyzed.
Cytotoxicity Assay
Epithelial cells (4 × 104 cells/well) were added to a 96-well plate
and cultured with increasing concentrations of enrofloxacin or
PHMB at 37◦C for 24 h. Non-treated cells and medium only
were used as controls. Resazurin sodium salt (Sigma–Aldrich,
United Kingdom) was prepared as a stock solution at 440 µM
in PBS and added to each well at 44 µM final concentration
and plates were incubated for an additional 48 h. Optical
density (OD) was then measured using a Tecan Infinite plate
reader (Tecan group Ltd, Switzerland) at 550 and 630 nm.
The OD value change (or % dye reduction) is proportional to
the viable cell number and was used to calculate half maximal
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inhibitory concentrations (IC50) values based on the intercept
theorem.
Development of Biofilms
Biofilms were developed according to the protocol described
by Prenafeta et al. (2014) with modifications. Briefly, S. aureus
strains were cultured overnight in a TSB medium, supplemented
with 2% glucose at 37◦C in an incubator shaker. The overnight
cultures were diluted to a final concentration of 107 cfu/mL
in a new fresh TSB medium. Aliquots of bacteria (1 mL, 107
cfu/mL) were added into a 12 wells cell culture plate and further
incubated in a 37◦C incubator for 48 h. After 48 h, the non-
adhered cultures were removed by pipette. To increase stability
of the biofilms, the biofilms were heat-fixed at 60◦C for 1 h.
Following that, 1 mL of 0.1% crystal violet diluted in water was
added to stain the biofilms for 15 min at room temperature.
After that, the crystal violet solution was removed by pipette,
and the biofilms were rinsed once with water. Biofilms mass was
quantified by measuring optical density of crystal violet at 550 nm
using spectrophotometer.
Visualization of Biofilms Using
Microscopy
Staphylococcus aureus was grown overnight as described above.
Biofilms were developed on glass cover slips in a 12 wells
cell culture plate. Following 48 h of incubation at 37◦C, the
non-adhered cells were removed and biofilms were heat fixed at
60◦C. Biofilms were fixed with 4% paraformaldehyde followed by
DAPI and WGA staining.
Anti-Biofilms Activity of Enrofloxacin and
PHMB
The biofilms were developed as described above. Following
48 h of incubation at 37◦C, antimicrobials (enrofloxacin and
PHMB) were slowly added to the wells, without removal of the
non-adhered cells, and the plates were further incubated at 37◦C
for another 3 h. Following that, the medium was removed and
the remaining biofilms were heat fixed, stained with crystal violet,
rinsed and proceed for OD measurement. Anti-biofilm activity of
antimicrobials was measured based on the percentage reduction
of biofilm mass in comparison to the untreated biofilms. To
determine whether bacteria within the treated were viable, the
biofilms were disrupted by sonication for 5 min in a bath
sonicator to release the individual cells, serial diluted in normal
saline, and plated onto nutrient agar for colony counting (Bjerkan
et al., 2009).
Statistical Analysis
All experiments were performed in triplicate. Statistical analysis
was performed using one-way Analysis of Variance (ANOVA)
followed by Tukey tests using the statistical packages Prism 6,
Version 6.0 (GraphPad Prism 6.0, San Diego, CA, United States).
Data is presented as means ± standard deviation. Differences
were scored as statistically significant where p ≤ 0.05. For
histogram and graphs, error bars represent standard deviations.
∗p ≤ 0.05, ∗∗∗p ≤ 0.001, ∗∗∗∗p ≤ 0.0001, ns (not significant).
RESULTS
Susceptibility of S. aureus Strains to
Enrofloxacin and PHMB
To measure susceptibility of S. aureus to enrofloxacin and PHMB,
MIC values were determined for all three strains tested; strain
15AL, 59 and 204. Both antimicrobials displayed potent growth
inhibitory effects. The MIC values for enrofloxacin were as
follows: 0.125 mg/L for strains 59 and 204, and 0.25 mg/L for
strain 15A, lower than PHMB in all three strains tested. The MIC
value for PHMB for all three strains tested were 1 mg/L.
Intracellular Invasion of Mac-T Cells by
S. aureus
To determine bactericidal activities of enrofloxacin and PHMB
against intracellular S. aureus, an in vitro intracellular infection
assay was established using Mac-T cells as host. The Mac-T
cell line was established from the bovine mammary alveolar
primary cells (Huynh et al., 1991). It is commonly used as
a model for udder epithelial cells and as a host for bacterial
intracellular infections (Bayles et al., 1998; Dogan et al.,
2006). Intracellular infections were performed using gentamicin
protection assay as described in our previous work with
keratinocytes (Kamaruzzaman et al., 2016). The same procedure
used for S. aureus invasion in keratinocytes was reproducible in
this cell culture model. All three S. aureus strains included in this
study invaded the host cells, as indicated by their ability to evade
gentamicin treatment (Figure 2). Gentamicin is an antibiotic that
is active against extracellular bacteria, but not against intracellular
bacteria, due to its polar properties and poor penetration into
mammalian cells (Vaudaux and Waldvogel, 1979). S. aureus
invasion of the host cells was further confirmed by visualization
using confocal microscopy. Using three-dimensional imaging
analysis, we observed localization of S. aureus strain 15 AL
(blue dots) inside Mac-T cells membranes (red) (Figure 3),
confirming invasion of S. aureus in host cells. These results show
that the S. aureus isolated from cases of bovine mastitis are
invasive.
Bactericidal Activities Enrofloxacin and
PHMB against Intracellular S. aureus
To investigate bactericidal activities of enrofloxacin and PHMB
against intracellular S. aureus, host cells were infected with
S. aureus and exposed to gentamicin to kill extracellular
bacteria, as described above. Infected cells were treated with
enrofloxacin or PHMB at 5, 10, or 15 mg/L for 3 h followed
by enumeration of cfu of surviving intracellular bacteria.
Figure 4 shows the percentages of surviving intracellular
S. aureus after treatment with enrofloxacin and PHMB, relative
to the untreated infected cells. Enrofloxacin at 15 mg/L killed
between 42 and 92% of intracellular S. aureus and PHMB
at 15 mg/L killed 99.9% of intracellular S. aureus. Therefore,
while both enrofloxacin and PHMB demonstrated activities
against intracellular S. aureus, PHMB showed more potent and
consistent bactericidal activities in comparison with enrofloxacin
against intracellular S. aureus.
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FIGURE 2 | Staphylococcus aureus invasion in Mac-T cells. Colony forming units (cfu) of S. aureus following gentamicin exposure. After gentamicin exposure, lysis
of Mac-T cells released approximately 105 cfu/mL of S. aureus 15AL (A), 104 cfu/mL of 59 (B), and 105 cfu/mL of 204 (C).
FIGURE 3 | Localization of S. aureus in Mac-T cells. Invasion of S. aureus 15
AL in Mac-T cells was visualized using confocal microscopy. Prior to imaging,
cells were stained with DAPI (blue) for epithelial cells and 15 AL DNA staining
and WGA (red) for host cells membrane staining. Confocal microscopy
z-stack projection moved through 139 slices across the cell. (a) Horizontal
cross-section of Mac-T cells (b) Vertical cross-section of Mac-T cells. The
small blue dots are S. aureus 15AL cells inside Mac-T cells, indicating
invasion. White scale bar is 7.5 µm.
PHMB Uptake into Mac-T Cells
Killing of intracellular S. aureus by antimicrobials normally
requires drug entry into the host cells and direct contact with
the bacteria. To test whether PHMB can enter Mac-T cells,
PHMB-FITC was added to the cell cultures and its intracellular
localization was tracked using confocal microscopy. As can be
seen in Figure 5A, a mixture of predominantly diffuse and
small-punctate spots of PHMB-FITC were observed, with a
relatively small proportion of PHMB-FITC apparent within
nuclei. To quantify PHMB entry into the cells, we analyzed
treated cells using flow cytometry. Consistent with microscopy
results, flow cytometry data indicate that PHMB-FITC entered
approximately 70% of cells (Figure 5B).
Colocalization of PHMB and Intracellular
S. aureus in Mac-T Cells
In the previous experiment, we showed that PHMB killed
intracellular S. aureus and entered Mac-T cells. To further
understand possible interactions between PHMB and
intracellular S. aureus, the host cells were infected with the
bacteria and exposed to PHMB-FITC. Interactions between
intracellular S. aureus and PHMB-FITC inside the host cells were
viewed using confocal microscopy.
As can be seen in Figure 6, colocalization of blue-stained
bacteria and green PHMB-FITC was apparent inside host
cells, as indicated by red-stained membrane structures. Indeed,
colocalization of PHMB-FITC and S. aureus in Mac-T cells was
apparent for the majority of intracellular bacteria in all cells
examined. Therefore, PHMB-FITC appears to directly access
intracellular S. aureus inside the host cells, suggesting direct
killing of intracellular bacteria in this cell culture model.
Enrofloxacin and PHMB Toxicities
toward Mac-T Cells
Resazurin assays were performed to determine the toxicity levels
of enrofloxacin and PHMB against Mac-T cells. The half maximal
inhibitory concentrations (IC50) for enrofloxacin and PHMB
were 345 ± 91 and 21 ± 2 mg/L, respectively. Therefore, Mac-T
cells tolerated both compounds at concentrations that were
higher than the concentrations required to kill more than 90%
of intracellular S. aureus; enrofloxacin (15 mg/L) and PHMB
(15 mg/L). These results indicate that both compounds can be
used to kill intracellular S. aureus with a high therapeutic index,
at least in these in vitro model systems.
Biofilms Formation and Visualization
To compare biofilm formation by S. aureus strains used in this
study, the mass of biofilm produced by each strain were measured
using crystal violet staining assay. We observed that incubation
of the bacteria for 48 h produced the highest amount of biofilm
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FIGURE 4 | Bactericidal activities of enrofloxacin and PHMB against intracellular S. aureus 15 AL, 59, and 204. Mac-T cells infected with S. aureus strain 15 AL, 59,
or 204 were either untreated or treated with increasing concentrations of enrofloxacin or PHMB. Untreated cultures were used to establish cfu values corresponding
to 100% survival.
FIGURE 5 | Fluorescein-tagged PHMB (PHMB-FITC) uptake into Mac-T cells. (A) PHMB-FITC localization visualized by confocal microscopy. Free FITC was used as
control. (B) PHMB-FITC uptake was quantified by flow cytometry. The small image represents the population of Mac-T cells gated in the analysis. The overlay
histogram image illustrates the uptake of PHMB-FITC into Mac-T cells. The green profile shows the population of cells treated with FITC and serves as a negative
control. The blue profile shows the population of cells treated with PHMB-FITC. Uptake of PHMB-FITC was observed in approximately 70% of Mac-T cells.
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FIGURE 6 | Colocalization of PHMB-FITC with intracellular S. aureus 15 AL inside Mac-T cells. Mac-T cells were infected with S. aureus strain 15 AL followed by
treatment with PHMB-FITC (green). Prior to microscopy, cells were labeled with DAPI (blue) and WGA (red). Upper panels are images of infected cells visualized
using filters for DAPI, FITC, and WGA, and merged images. Lower panels are enlarged images that clearly show colocalization between PHMB-FITC (green) and
S. aureus 15AL (blue dots). White scale bar is 25 µM.
FIGURE 7 | Biofilms’ mass of three S. aureus strains measured by crystal
violet staining. Biofilms were grown for 48 h and stained with crystal violet.
The biofilms’ mass was quantified by measuring the optical density of crystal
violet at 550 nm using spectrophotometer.
as indicated by highest OD upon staining with crystal violet.
Prolonging the incubation time to 72 h or more reduced the
amount of the biofilm produced. Of all three strains tested;
15 AL, 204, and 59, strain 15AL produced the most biofilms
(Figure 7). To further confirm the structure and thickness
of biofilms, the biofilms of strain 15 AL were imaged using
confocal microscopy. Using the three dimensional projection, we
confirmed the structure of biofilms was composed of stacks of
5-7 bacteria grown on top of each other, with thickness was in
between 7.9± 0.5 µm (Figure 8).
Anti-biofilms Activities of Enrofloxacin
and PHMB
To investigate anti-biofilms activities of enrofloxacin and PHMB,
biofilms were grown as previously described. Due to instability
FIGURE 8 | Visualization of S. aureus biofilms using confocal microscopy.
Biofilms of S. aureus 15 AL were grown for 48 h. Prior to imaging, biofilms
were stained with DAPI (blue) for S. aureus nuclei staining and WGA (red) for
N-acetylglucose amine staining. Confocal microscopy z-stack projection
moved through 111 slices across the cell. (a) Horizontal cross-section of
biofilms (b) Vertical cross-section of biofilms. White scale bar is 7.5 µm.
of the biofilms produced by strain 204, only biofilms produced
by strain 15 AL and 59 were tested. After 48 h, biofilms of both
strains were treated with enrofloxacin or PHMB at 5, 10, or
15 mg/L for 3 h and stained with crystal violet to expose mass
of remaining biofilms. Figure 9 shows percentages of biofilm
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FIGURE 9 | Anti-biofilms activities of enrofloxacin and PHMB. Biofilms of S. aureus strain 15 AL and 59 were either untreated or treated with increasing
concentrations of enrofloxacin or PHMB. Untreated biofilms were used as a positive control, corresponding to 100% biofilms’ mass.
mass after treatment with enrofloxacin or PHMB, relative to the
untreated biofilms (100%). Enrofloxacin at 15 mg/L reduced 10
and 27% of biofilms S. aureus strain15 AL and 59, respectively.
PHMB at 15 mg/L reduced 28 and 37% of biofilms 15 AL and
59, respectively. Therefore, while both antimicrobials displayed
anti-biofilms activities, PHMB was more potent in disrupting the
biofilms of both strains. In addition, both antimicrobials were
effective in killing biofilm bacteria (Supplementary Figure S1).
DISCUSSION
Host cell invasion and the formation of biofilms are believed to
be among the main factors leading to S. aureus mastitis treatment
failures. Here we tested two antimicrobials, enrofloxacin and
PHMB against intracellular and biofilms forms of S. aureus.
We demonstrated that both enrofloxacin and PHMB killed
intracellular S. aureus and displayed anti-biofilm activities.
PHMB activities against intracellular S. aureus appears
through direct interactions with the bacteria inside the host
cells.
The low MIC values for both enrofloxacin and PHMB suggest
that all internalized S. aureus are likely to be susceptible to
killing by both compounds, provided the antimicrobial reaches
bactericidal concentrations inside the host cells. Enrofloxacin is
a fluoroquinolone that displays concentration dependent killing
against extracellular bacteria and can enter mammalian cells
(Schoevers et al., 1999). Thus, we anticipated that enrofloxacin
would display the same killing activities against all intracellular
S. aureus. However, variable activities and incomplete clearance
of the bacteria indicates that the intracellular milieu reduces
potency. Similarly, Schoevers et al. (1999) demonstrated that
intracellular S. aureus in porcine alveolar macrophages are less
susceptible to enrofloxacin, and Vallet et al. (2011) demonstrated
incomplete clearance of intracellular S. aureus when treated with
gemifloxacin. Furthermore, higher cellular drug accumulation
did not always lead to higher intracellular activity, possibility
due to drug binding non-specifically to intracellular components
(Vallet et al., 2011).
PHMB in contrast, displayed bactericidal activities against
all intracellular S. aureus tested. This finding agrees with our
previous report of the bactericidal activities of PHMB against
intracellular S. aureus in keratinocytes (Kamaruzzaman et al.,
2016). In this and a related study on intracellular parasites, we
found that that PHMB uptake into mammalian cells is through
dynamin-dependent endocytic mechanism (Firdessa et al., 2015;
Kamaruzzaman et al., 2016). The compound is first trapped
within endosomes that could latter rupture due to two possible
mechanisms; (1) The “flip-flop” mechanism, where interaction of
the positive charge of the cationic biguanide can cause anionic
phospholipid from cytosol leaflet to flip into intraluminal side of
the endosome, thus causing destabilization of the structure and
released of the cargo into the cytosol or, (2) The “proton-sponge
effect” where protonation of PHMB in acidic endolysosome
can induces extensive inflow of ions and water into the
compartments, subsequently causing rupture of the membrane
and released of the compound into the cytosol (Varkouhi et al.,
2011). Once released into the cytosol, the compound could
then enter the nuclei, although most of the polymer appears
to be excluded. The predominantly diffuse and some punctate
localization of PHMB-FITC inside the host cells suggests that
this compound may have accessed to the cytosol and endosomal
compartments, where S. aureus would normally localize, similar
to our previous observations in keratinocytes. However, higher
concentrations of PHMB (15 mg/L) were required to kill
intracellular S. aureus in bovine mammary epithelial cells
compared to intracellular S. aureus in keratinocytes (4 mg/L),
suggesting that changes in bacterial physiology in these host cells
or host cells factors may inhibit PHMB activities (Kamaruzzaman
et al., 2016). This is supported by our observations of
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PHMB-FITC uptake in only 70% of Mac-T cells, compared to
99% in keratinocytes (Kamaruzzaman et al., 2016). Nonetheless,
colocalization of PHMB with the majority of S. aureus inside
bovine mammary epithelial cells suggests that PHMB enters
Mac-T cells, and then directly binds and kills intracellular
bacteria.
PHMB’s antibacterial activities appear to be due, in part, to
the biguanide groups interacting with cytoplasmic membranes,
lipopolysaccharidse and peptidoglycan of the bacterial cell wall.
This binding could displace the divalent cation Ca2+, causing
membrane destabilization and cellular leakages (Gilbert and
Moore, 2005). Also, the hexamethylene segment can interact
with phospholipids on the membrane, causing a phase separation
that disturbs random distribution of lipids, further destabilizing
the membrane structure (Broxton et al., 1984). Furthermore,
recent findings in our laboratory demonstrated that PHMB
can enter bacteria cells and condense bacterial chromosomes
(Chindera et al., 2016). PHMB has a strong affinity toward
DNA which is believe due to the strong electrostatic interaction
between the negatively charged phosphate backbone of DNA
and the cationic charged of polymer PHMB (Firdessa et al.,
2015). Therefore, PHMB’s antimicrobial activities involve several
mechanisms.
In this study, enrofloxacin was only effective in disrupting
the biofilms from one of the two strains tested, suggesting
strain dependent anti-biofilms activities. Variability between
biofilms of different S. aureus strains treated by a delafloxacin
(a fluoroquinolone) was also reported by Siala et al. (2014).
The study suggests that different chemical compositions and
biophysical properties of the biofilms associated with different
strains affects the penetration of the enrofloxacin inside the
biofilms (Siala et al., 2014). In contrast, PHMB was more effective
in disrupting biofilms structure, despite being a larger molecule.
We cannot provide a detailed explaination of PHMB effects on
biofilms; however, PHMB is a positively charged polymer that can
interact with DNA through electrostatic interactions (Firdessa
et al., 2015). Biofilms are composed of self-produced extracellular
polymeric substances (EPS) that consist of polysaccharide,
extracellular DNA, protein and lipids. The role of extracellular
DNA is to promote adhesion of the bacteria to the surfaces and
to provide structural integrity to the EPS structure (Okshevsky
and Meyer, 2013). Thus, the anti-biofilms effects we observed
could be due to interactions between PHMB with the EPS
structure.
CONCLUSION
There are three main findings from this study. First, both
enrofloxacin and PHMB are effective against intracellular
S. aureus. Second, PHMB directly binds to intracellular S. aureus
in the Mac-T cells. Third, both compounds also have anti-biofilm
activities. These findings demonstrate that PHMB is an effective
antimicrobial polymer against intracellular and biofilm forms of
S. aureus, and this polymer appears to have potential as a future
therapy for the treatment of mastitis, a disease that involves
difficult to treat S. aureus infections.
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